ABCL News and Press, AbCellera Biologics Inc. From 11/02/21

AbCellera (Nasdaq: ABCL) today announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for administration together. This neutralizing antibody therapy is authorized for emergency use for the treatment of mild to mod...

AbCellera shares have been rocked by news of Merck's "COVID pill" treatment, sending shares down 25% from recent highs. In September, AbCellera's current antibody therapy was put back into use after an FDA pause, giving the company back a key revenue source. The company's pan vari...

AbCellera (Nasdaq: ABCL) will announce its third quarter 2021 financial results on Tuesday, November 9, 2021, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. The live webcast of the earnings conference will be available throu...

Shares of AbCellera Biologics (NASDAQ: ABCL) gained 19.4% in September, according to data from S&P Global Market Intelligence . The stock jumped in the middle of the month after the biotech company announced that it had formed a new partnership with Moderna and continued...

Baker Brothers’ 13F portfolio value decreased from $23.07B to $22.77B this quarter. The InVitae stake was reduced this quarter while increasing Apellis Pharma and Heron Therapeutics. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almo...

Stanley Druckenmiller’s 13F portfolio value decreased from $3.89B to $3.48B this quarter. Duquesne added Netflix & Airbnb and increased Alphabet & Carvana while reducing Sea Limited and dropping Citigroup. The top three positions are at ~29% of the portfolio. ...

Growth and value equities have taken a hit in September, which is historically a terrible month for stocks, the politics of a shutdown and potential default look to be temporary headwinds. I am feeling very good at the moment regarding my positions and exposure to durable trends in th...

Halvorsen's 13F portfolio value decreased marginally from $33.58B to $32.98B this quarter. The number of positions decreased from 94 to 88. Viking Global added FIGS Inc. & JD.com and increased Amazon.com & General Electric during the quarter. The top three positions are Am...

On September 5th, Berkeley Lights was hit by short seller Scorpion Capital, knocking the stock down roughly 30%. The report does raise some interesting questions regarding the business Berkeley operates in, one must also consider that at the current level, many of these concerns may b...

10-target partnership leverages AbCellera’s technology to accelerate Everest’s pipeline of novel, innovative medicines to patients AbCellera (Nasdaq: ABCL) and Everest Medicines Limited (HKEX 1952.HK, “Everest”) announced today that they h...